Register for our S/EIS Fund

Pleased to share that Claudio Dagostin, VP of Business Development, will be representing o2h discovery at the Genesis 2021 tomorrow.

Genesis 2021 creates a platform that enables business development and technology scouting teams of larger corporates to engage with early-stage R&D companies and institutions.

o2h discovery is a Contract Research Organisation which has an integrated drug discovery platform operating from our state-of-the-art research centre in India and The Mill SciTech Park, Cambridge, UK. We have the in-house capability to execute hit-lead-optimization programs leading into patent and IND filing from our state-of-the-art biotechnology incubator with expertise in discovery chemistry, biology, pharmacology, and the ongoing project management of pre-clinical development.


The event is returning face-to-face in a new venue and format to retain the positives of in-person and virtual events, 2021 can be considered something of a re-genesis, as we reconnect and regenerate the biotech ecosystem.

For more information about the event, please see – https://lnkd.in/ec-FEeD